Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive Disorder [Phase 1]

View source ↗

Summary

A Phase 1 study assessing safety, tolerability, and pharmacodynamics of JNJ-54175446 in adults with Major Depressive Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• JNJ-54175446

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 1 | Status: COMPLETED